189 related articles for article (PubMed ID: 37303667)
1. Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma.
Zhao A; Wang Z; Wang Y; Chen X
Am J Transl Res; 2023; 15(5):3131-3151. PubMed ID: 37303667
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
3. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
Zhan Z; Lin K; Wang T
BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
[TBL] [Abstract][Full Text] [Related]
4. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma.
Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC
BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490
[TBL] [Abstract][Full Text] [Related]
5. Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.
Li Y; Cai H; Yang J; Xie X; Pei S; Wu Y; Zhang J; Song G; Zhang J; Zhang Q; Chi H; Yang G
Front Pharmacol; 2023; 14():1264345. PubMed ID: 37822877
[No Abstract] [Full Text] [Related]
6. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.
Chen Y; Chen X; Wang X
Front Cell Dev Biol; 2022; 10():973073. PubMed ID: 36111345
[TBL] [Abstract][Full Text] [Related]
7. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
Front Immunol; 2022; 13():847624. PubMed ID: 35242144
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.
Lei P; Xue L; Wu Y; Zhong J
Bioengineered; 2022; 13(7-12):15033-15044. PubMed ID: 37105900
[TBL] [Abstract][Full Text] [Related]
9. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
10. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
[TBL] [Abstract][Full Text] [Related]
13. BAG2 Is a Novel Prognostic Biomarker and Promising Immunotherapy Target in Uveal Melanoma.
Li C; Shi H
Crit Rev Eukaryot Gene Expr; 2023; 33(6):55-71. PubMed ID: 37522545
[TBL] [Abstract][Full Text] [Related]
14. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract][Full Text] [Related]
16. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
Wan Q; Ren X; Tang J; Ma K; Deng YP
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
[TBL] [Abstract][Full Text] [Related]
17. Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma.
Xu J; Zhao Y; Sun H; Xiao Q; Ye P
Int J Gen Med; 2021; 14():4639-4651. PubMed ID: 34434056
[TBL] [Abstract][Full Text] [Related]
18. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
20.
Luo Y; Ni R; Jin X; Feng P; Dai C; Jiang L; Chen P; Yang L; Zhu Y
Heliyon; 2023 Nov; 9(11):e21333. PubMed ID: 38027647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
